Top Buy
| Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc | 33 | 0 | 3 | 0 | €99.66 | €182.69 | 83.312% |
| Johnson & Johnson | 41 | 1 | 6 | 0 | €146.04 | €192.63 | 31.902% |
| Karyopharm Therapeutics Inc. | 8 | 1 | 0 | 0 | €0.81 | €5.49 | 579.842% |
| Kezar Life Sciences | 6 | 0 | 0 | 0 | €0.76 | €18.35 | 2329.801% |
| Knight Therapeutics | 1 | 0 | 0 | 0 | €3.86 | €10.00 | 159.067% |
| Krystal Biotech | 19 | 0 | 1 | 0 | €161.40 | €184.02 | 14.015% |
| Lexicon Pharmaceuticals Inc. | 12 | 0 | 3 | 0 | €1.54 | €9.07 | 490.717% |
| Lisata Therapeutics Inc. | 1 | 0 | 0 | 0 | €2.52 | €4.00 | 58.730% |
| MacroGenics Inc. | 14 | 0 | 2 | 0 | €3.28 | €12.31 | 275.611% |
| MannKind Corp. | 12 | 0 | 3 | 0 | €5.92 | €6.92 | 17.014% |
| Medpace Holdings Inc | 18 | 0 | 2 | 0 | €312.60 | €408.19 | 30.578% |
| Merck & Co. Inc. | 32 | 1 | 2 | 0 | €100.00 | €126.38 | 26.380% |
| Merck KGaA | 8 | 1 | 4 | 0 | €155.30 | €172.00 | 10.753% |
| MorphoSys AG | 6 | 0 | 0 | 0 | €67.40 | €65.00 | -3.561% |
| MPH Health Care AG | 1 | 0 | 0 | 0 | €24.60 | - | - |
| Nektar Therapeutics | 5 | 1 | 1 | 0 | €1.20 | €2.99 | 149.525% |
| Newron Pharmaceut. | 3 | 0 | 2 | 0 | €8.26 | - | - |
| Novartis AG ADR | 4 | 0 | 1 | 0 | €104.00 | €112.40 | 8.074% |
| Novavax Inc. | 6 | 1 | 1 | 0 | €12.40 | €21.98 | 77.162% |
| Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €195.00 | 5.405% |
| Novo Nordisk A/S ADR | 25 | 1 | 4 | 0 | €105.00 | €144.48 | 37.600% |
| Omeros Corp. | 2 | 2 | 0 | 0 | €3.49 | - | - |
| Pacira Pharmaceuticals | 22 | 1 | 1 | 0 | €14.10 | €40.02 | 183.830% |
| Personalis Inc | 11 | 1 | 1 | 0 | €4.72 | €7.29 | 54.335% |
| Pfizer Inc. | 29 | 4 | 5 | 0 | €26.04 | €40.64 | 56.078% |